Efficacy of the Nicotine Inhaler as an Adjunct to Smoking Cessation

Scott Leischow, Fredrik Nilsson, Mikael Franzon, Anabel Hill, Pamela Otte, Elizabeth P. Merikle

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

A randomized double-blind placebo-controlled clinical trial was conducted to assess the efficacy of a nicotine inhaler as an adjunct to smoking cessation. One hundred eleven subjects were randomized to each condition. Subjects received brief individual support regarding proper inhaler use and smoking cessation. Inhalers were used on an ad libitum dose for 3 months. Significant differences in abstinence rates between the two groups were found at 6 weeks, 3 months, and 6 months but not at 12 months after quit day. These results indicate that the nicotine inhaler is an efficacious adjunct to smoking cessation.

Original languageEnglish (US)
Pages (from-to)364-371
Number of pages8
JournalAmerican Journal of Health Behavior
Volume20
Issue number5
StatePublished - Dec 1 1996

Fingerprint

Nebulizers and Vaporizers
Smoking Cessation
Nicotine
nicotine
smoking
Controlled Clinical Trials
Placebos
Group

ASJC Scopus subject areas

  • Health(social science)
  • Social Psychology
  • Public Health, Environmental and Occupational Health

Cite this

Leischow, S., Nilsson, F., Franzon, M., Hill, A., Otte, P., & Merikle, E. P. (1996). Efficacy of the Nicotine Inhaler as an Adjunct to Smoking Cessation. American Journal of Health Behavior, 20(5), 364-371.

Efficacy of the Nicotine Inhaler as an Adjunct to Smoking Cessation. / Leischow, Scott; Nilsson, Fredrik; Franzon, Mikael; Hill, Anabel; Otte, Pamela; Merikle, Elizabeth P.

In: American Journal of Health Behavior, Vol. 20, No. 5, 01.12.1996, p. 364-371.

Research output: Contribution to journalArticle

Leischow, S, Nilsson, F, Franzon, M, Hill, A, Otte, P & Merikle, EP 1996, 'Efficacy of the Nicotine Inhaler as an Adjunct to Smoking Cessation', American Journal of Health Behavior, vol. 20, no. 5, pp. 364-371.
Leischow S, Nilsson F, Franzon M, Hill A, Otte P, Merikle EP. Efficacy of the Nicotine Inhaler as an Adjunct to Smoking Cessation. American Journal of Health Behavior. 1996 Dec 1;20(5):364-371.
Leischow, Scott ; Nilsson, Fredrik ; Franzon, Mikael ; Hill, Anabel ; Otte, Pamela ; Merikle, Elizabeth P. / Efficacy of the Nicotine Inhaler as an Adjunct to Smoking Cessation. In: American Journal of Health Behavior. 1996 ; Vol. 20, No. 5. pp. 364-371.
@article{c452345fbb6d41c88c7007954cd2bb59,
title = "Efficacy of the Nicotine Inhaler as an Adjunct to Smoking Cessation",
abstract = "A randomized double-blind placebo-controlled clinical trial was conducted to assess the efficacy of a nicotine inhaler as an adjunct to smoking cessation. One hundred eleven subjects were randomized to each condition. Subjects received brief individual support regarding proper inhaler use and smoking cessation. Inhalers were used on an ad libitum dose for 3 months. Significant differences in abstinence rates between the two groups were found at 6 weeks, 3 months, and 6 months but not at 12 months after quit day. These results indicate that the nicotine inhaler is an efficacious adjunct to smoking cessation.",
author = "Scott Leischow and Fredrik Nilsson and Mikael Franzon and Anabel Hill and Pamela Otte and Merikle, {Elizabeth P.}",
year = "1996",
month = "12",
day = "1",
language = "English (US)",
volume = "20",
pages = "364--371",
journal = "American Journal of Health Behavior",
issn = "1087-3244",
publisher = "PNG Publications",
number = "5",

}

TY - JOUR

T1 - Efficacy of the Nicotine Inhaler as an Adjunct to Smoking Cessation

AU - Leischow, Scott

AU - Nilsson, Fredrik

AU - Franzon, Mikael

AU - Hill, Anabel

AU - Otte, Pamela

AU - Merikle, Elizabeth P.

PY - 1996/12/1

Y1 - 1996/12/1

N2 - A randomized double-blind placebo-controlled clinical trial was conducted to assess the efficacy of a nicotine inhaler as an adjunct to smoking cessation. One hundred eleven subjects were randomized to each condition. Subjects received brief individual support regarding proper inhaler use and smoking cessation. Inhalers were used on an ad libitum dose for 3 months. Significant differences in abstinence rates between the two groups were found at 6 weeks, 3 months, and 6 months but not at 12 months after quit day. These results indicate that the nicotine inhaler is an efficacious adjunct to smoking cessation.

AB - A randomized double-blind placebo-controlled clinical trial was conducted to assess the efficacy of a nicotine inhaler as an adjunct to smoking cessation. One hundred eleven subjects were randomized to each condition. Subjects received brief individual support regarding proper inhaler use and smoking cessation. Inhalers were used on an ad libitum dose for 3 months. Significant differences in abstinence rates between the two groups were found at 6 weeks, 3 months, and 6 months but not at 12 months after quit day. These results indicate that the nicotine inhaler is an efficacious adjunct to smoking cessation.

UR - http://www.scopus.com/inward/record.url?scp=0030503311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030503311&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0030503311

VL - 20

SP - 364

EP - 371

JO - American Journal of Health Behavior

JF - American Journal of Health Behavior

SN - 1087-3244

IS - 5

ER -